Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleLeukemia drug heralds molecularly targeted era.AuthorsVastag, Brian; Vastag, BAbstractIntroduces STI-571, a drug that selectively targets chronic myelogenous leukemia cells without any of the traditional chemotherapy side effects. Information on its development; Comments on the drug; Results of clinical trials.SubjectsDRUGS; MYELOID leukemia; LEUKEMIA treatment; DRUG developmentPublicationJNCI: Journal of the National Cancer Institute, 2000, Vol 92, Issue 1, p6ISSN0027-8874Publication typejournal articleDOI10.1093/jnci/92.1.6